Holen Sie sich die Stockscreener-App
0.7422
4.11%
0.0292
Immunic Inc Aktie (IMUX) Neueste Nachrichten
Financial Metrics Check: Immunic Inc (IMUX)’s Ratios for Trailing Twelve Months - DWinneX
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of “Buy” by Brokerages - Defense World
Immunic Post-Readout: Reiterating Strong Buy As Big Drop Appears Unwarranted (NASDAQ:IMUX) - Seeking Alpha
Millennium Management LLC Has $580,000 Stake in Immunic, Inc. (NASDAQ:IMUX) - Defense World
Immunic completes Phase 3 multiple sclerosis trial enrollmentICYMI - Proactive financial news
Immunic Therapeutics reaches major milestone with completion of ENSURE Trial Enrollment - Proactive financial news
Immunic at Jefferies Conference: Promising MS Drug Insights By Investing.com - Investing.com South Africa
Immunic at Jefferies Conference: Promising MS Drug Insights - Investing.com Australia
Small cap wrap: Midnight Sun Mining, Standard Uranium, Immunic, ReconAfrica... - Proactive Investors
Market movers: Tesla, Verint, PVH, Immunic... - Proactive financial news
Immunic (IMUX) Receives Continued 'Buy' Rating from D. Boral Cap - GuruFocus
Immunic (IMUX) Receives Continued 'Buy' Rating from D. Boral Capital | IMUX Stock News - GuruFocus
Immunic completes patient enrollment in Phase 3 relapsing multiple sclerosis trials - Proactive financial news
Immunic Completes Enrollment in 2 Phase 3 Studies in Relapsing Multiple Sclerosis - MarketScreener
IMUX: Promising Results of Vidofludimus Calcium in Multiple Scle - GuruFocus
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS - The Malaysian Reserve
Immunic Announces Completion of Enrollment for Both Phase 3 ENSU - GuruFocus
IMUX Completes Enrollment for Phase 3 Trials in Multiple Sclerosis | IMUX Stock News - GuruFocus
Top Executives Make Bold Moves with Major Immunic Stock Purchases! - TipRanks
Immunic Approves Equity Plan Amendment at Annual Meeting - TipRanks
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering | IMUX Stock News - GuruFocus
Immunic Announces Closing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - Longview News-Journal
Immunic raises $65M in public offering to fund clinical trials - Proactive financial news
Immunic to Participate in Investor, Scientific and Industry Conf - GuruFocus
Immunic to Participate in Investor, Scientific and Industry Conferences in June - The Malaysian Reserve
Immunic releases June conference schedule - Proactive financial news
Immunic Announces $65 Million Public Offering - TipRanks
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Eastern Progress
Immunic Inc. prices $65 million public offering By Investing.com - Investing.com South Africa
Immunic (NASDAQ:IMUX) Price Target Lowered to $10.00 at D. Boral Capital - Defense World
Immunic (IMUX) Launches $65M Public Offering, Shares Drop - GuruFocus
Immunic Tumbles After Pricing $65 Million Offering of Warrants - marketscreener.com
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Un - GuruFocus
Small cap wrap: Fineqia, Synchronoss, Santacruz Silver, Immunic... - Proactive financial news
Immunic (IMUX) Receives Target Price Adjustment from D. Boral Ca - GuruFocus
Immunic (IMUX) Receives Target Price Adjustment from D. Boral Capital | IMUX Stock News - GuruFocus
Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering - GuruFocus
Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering | IMUX Stock News - GuruFocus
Immunic (IMUX) Launches Public Offering with Warrant Options | I - GuruFocus
Immunic shares fall 12% after pricing of $65 million underwritten public offering to fund trials - Seeking Alpha
Immunic to raise up to $65M in underwritten public offering - Proactive Investors
Immunic (IMUX) Launches Public Offering with Warrant Options | IMUX Stock News - GuruFocus
Immunic Announces Pricing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com
Immunic Inc. prices $65 million public offering - Investing.com
Immunic, Inc. Announces Proposed Public Offering - Longview News-Journal
Immunic launches public offering of warrants to fund clinical trials; shares down - MSN
Immunic slides on planned equity raise - TradingView
0.34%
7.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):